These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 11260387

  • 1. Increased cGMP phosphodiesterase activity mediates renal resistance to ANP in rats with bile duct ligation.
    Ni XP, Safai M, Gardner DG, Humphreys MH.
    Kidney Int; 2001 Apr; 59(4):1264-73. PubMed ID: 11260387
    [Abstract] [Full Text] [Related]

  • 2. Mechanisms contributing to renal resistance to atrial natriuretic peptide in rats with common bile-duct ligation.
    Ni X, Cheng Y, Cao L, Gardner DG, Humphreys MH.
    J Am Soc Nephrol; 1996 Oct; 7(10):2110-8. PubMed ID: 8915970
    [Abstract] [Full Text] [Related]

  • 3. Phosphodiesterase inhibitors correct resistance to natriuretic peptides in rats with Heymann Nephritis.
    Valentin JP, Ying WZ, Sechi LA, Ling KT, Qiu C, Couser WG, Humphreys MH.
    J Am Soc Nephrol; 1996 Apr; 7(4):582-93. PubMed ID: 8724892
    [Abstract] [Full Text] [Related]

  • 4. Increased activity of cGMP-specific phosphodiesterase (PDE5) contributes to resistance to atrial natriuretic peptide natriuresis in the pregnant rat.
    Ni XP, Safai M, Rishi R, Baylis C, Humphreys MH.
    J Am Soc Nephrol; 2004 May; 15(5):1254-60. PubMed ID: 15100365
    [Abstract] [Full Text] [Related]

  • 5. Increased renal phosphodiesterase-5 activity mediates the blunted natriuretic response to ANP in the pregnant rat.
    Knight S, Snellen H, Humphreys M, Baylis C.
    Am J Physiol Renal Physiol; 2007 Feb; 292(2):F655-9. PubMed ID: 17003222
    [Abstract] [Full Text] [Related]

  • 6. Cellular basis for blunted volume expansion natriuresis in experimental nephrotic syndrome.
    Valentin JP, Qiu C, Muldowney WP, Ying WZ, Gardner DG, Humphreys MH.
    J Clin Invest; 1992 Oct; 90(4):1302-12. PubMed ID: 1328296
    [Abstract] [Full Text] [Related]

  • 7. Effect of phosphodiesterase 5 inhibitor on alteration in vascular smooth muscle sensitivity and renal function in rats with liver cirrhosis.
    Tahseldar-Roumieh R, Ghali-Ghoul R, Lugnier C, Sabra R.
    Am J Physiol Heart Circ Physiol; 2006 Jan; 290(1):H481-8. PubMed ID: 16373593
    [Abstract] [Full Text] [Related]

  • 8. Cardiovascular effects of a novel, potent and selective phosphodiesterase 5 inhibitor, DMPPO: in vitro and in vivo characterization.
    Delpy E, le Monnier de Gouville AC.
    Br J Pharmacol; 1996 Jul; 118(6):1377-84. PubMed ID: 8832060
    [Abstract] [Full Text] [Related]

  • 9. Angiotensin-converting enzyme inhibition prevents myocardial infarction-induced increase in renal cortical cGMP and cAMP phosphodiesterase activities.
    Clauss F, Charloux A, Piquard F, Doutreleau S, Talha S, Zoll J, Lugnier C, Geny B.
    Fundam Clin Pharmacol; 2015 Aug; 29(4):352-61. PubMed ID: 25939307
    [Abstract] [Full Text] [Related]

  • 10. Cyclic GMP-specific phosphodiesterase 5 regulates growth and apoptosis in pulmonary endothelial cells.
    Zhu B, Strada S, Stevens T.
    Am J Physiol Lung Cell Mol Physiol; 2005 Aug; 289(2):L196-206. PubMed ID: 15792963
    [Abstract] [Full Text] [Related]

  • 11. Increased renal phosphodiesterase-5 activity mediates the blunted natriuretic response to a nitric oxide donor in the pregnant rat.
    Sasser JM, Ni XP, Humphreys MH, Baylis C.
    Am J Physiol Renal Physiol; 2010 Oct; 299(4):F810-4. PubMed ID: 20668100
    [Abstract] [Full Text] [Related]

  • 12. Characterization of a novel potent and specific inhibitor of type V phosphodiesterase.
    Coste H, Grondin P.
    Biochem Pharmacol; 1995 Nov 09; 50(10):1577-85. PubMed ID: 7503759
    [Abstract] [Full Text] [Related]

  • 13. Glucocorticoids improve renal responsiveness to atrial natriuretic peptide by up-regulating natriuretic peptide receptor-A expression in the renal inner medullary collecting duct in decompensated heart failure.
    Liu C, Chen Y, Kang Y, Ni Z, Xiu H, Guan J, Liu K.
    J Pharmacol Exp Ther; 2011 Oct 09; 339(1):203-9. PubMed ID: 21737535
    [Abstract] [Full Text] [Related]

  • 14. [Resistance to the action of atrial natriuretic peptide and urodilatin in Heymann nephritis in vitro].
    Valentin JP, Ying WZ, Sechi LA, Humphreys MH.
    Arch Mal Coeur Vaiss; 1994 Aug 09; 87(8):1125-9. PubMed ID: 7755473
    [Abstract] [Full Text] [Related]

  • 15. Increased activity of guanosine 3'-5'-cyclic monophosphate phosphodiesterase in the renal tissue of cirrhotic rats with ascites.
    Angeli P, Jiménez W, Veggian R, Fasolato S, Volpin R, MacHenzie HS, Craighero R, Libera VD, Sticca A, Arroyo V, Gatta A.
    Hepatology; 2000 Feb 09; 31(2):304-10. PubMed ID: 10655250
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of cGMP-specific phosphodiesterase type 5 reduces sodium excretion and arterial blood pressure in patients with NaCl retention and ascites.
    Thiesson HC, Jensen BL, Jespersen B, Schaffalitzky de Muckadell OB, Bistrup C, Walter S, Ottosen PD, Veje A, Skøtt O.
    Am J Physiol Renal Physiol; 2005 May 09; 288(5):F1044-52. PubMed ID: 15613622
    [Abstract] [Full Text] [Related]

  • 17. Stimulation of AQP2 membrane insertion in renal epithelial cells in vitro and in vivo by the cGMP phosphodiesterase inhibitor sildenafil citrate (Viagra).
    Bouley R, Pastor-Soler N, Cohen O, McLaughlin M, Breton S, Brown D.
    Am J Physiol Renal Physiol; 2005 Jun 09; 288(6):F1103-12. PubMed ID: 15644488
    [Abstract] [Full Text] [Related]

  • 18. Cyclic-GMP-binding, cyclic-GMP-specific phosphodiesterase (PDE5) gene expression is regulated during rat pulmonary development.
    Sanchez LS, de la Monte SM, Filippov G, Jones RC, Zapol WM, Bloch KD.
    Pediatr Res; 1998 Feb 09; 43(2):163-8. PubMed ID: 9475279
    [Abstract] [Full Text] [Related]

  • 19. Cyclic GMP and cGMP-binding phosphodiesterase are required for interleukin-1-induced nitric oxide synthesis in human articular chondrocytes.
    Geng Y, Zhou L, Thompson WJ, Lotz M.
    J Biol Chem; 1998 Oct 16; 273(42):27484-91. PubMed ID: 9765278
    [Abstract] [Full Text] [Related]

  • 20. Increased expression of the cGMP-inhibited cAMP-specific (PDE3) and cGMP binding cGMP-specific (PDE5) phosphodiesterases in models of pulmonary hypertension.
    Murray F, MacLean MR, Pyne NJ.
    Br J Pharmacol; 2002 Dec 16; 137(8):1187-94. PubMed ID: 12466227
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.